Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study

Atherosclerosis
Hsin-Hui YuBor-Luen Chiang

Abstract

The anti-inflammatory and cardiovascular protective effects of statin for patients with systemic lupus erythematosus (SLE) are not clear. We tested the hypothesis that statin use is associated with reduced mortality and morbidity in SLE patients with hyperlipidemia. We included 4095 patients with SLE and hyperlipidemia from the entire population using the Taiwan National Health Insurance Research Database between 1997 and 2008. A total of 935 matching sets (1:2) of patients who had never used lipid-lowering medications and statin users were included in the nested matched cohort. Cox proportional hazards regression was used to calculate the hazard ratios (HR) and 95% confidence intervals (CI) for the association between statin and all-cause mortality, coronary artery disease (CAD), cerebrovascular disease (CVD) and end-stage renal disease (ESRD), conditional for matching sets in the matched cohort. The multivariate adjusted hazard ratios (HR) for statin users, as compared with patients had never used lipid-lowering medications, were 0.67 (95% CI, 0.54 to 0.83) for death from any cause. High-dose statins (>365 cumulative defined daily dose) significantly reduced risk of all-cause mortality (HR 0.44, 95% CI 0.32 to 0.60); CAD (HR ...Continue Reading

References

Sep 10, 2005·Best Practice & Research. Clinical Rheumatology·Ian N Bruce
Apr 28, 2006·Nature Reviews. Immunology·John GreenwoodScott S Zamvil
May 1, 2007·Arthritis and Rheumatism·Peter E WesterweelMarianne C Verhaar
Aug 19, 2007·Rheumatology·S I van LeuvenP P Tak
Mar 20, 2008·Nature Clinical Practice. Rheumatology·Christy SandborgLaura Schanberg
Apr 1, 2009·Arthritis and Rheumatism·Gudrun E NorbyUNKNOWN Assessment of Lescol in Renal Transplantation Study Group
Dec 18, 2009·Autoimmunity·Yaniv ShererYehuda Shoenfeld
Sep 11, 2010·Expert Review of Cardiovascular Therapy·Gerard Pasterkamp, Guus W van Lammeren
Nov 12, 2010·Annals of the Rheumatic Diseases·Sander I van LeuvenAmy S Major
Dec 24, 2010·Annals of the Rheumatic Diseases·M A PetriL S Magder
Feb 26, 2011·Pharmacoepidemiology and Drug Safety·Ching-Lan ChengMing Liang Lai
Jun 2, 2011·Nature Reviews. Rheumatology·Deborah P M Symmons, Sherine E Gabriel
Oct 28, 2011·Arthritis and Rheumatism·L E SchanbergUNKNOWN Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yu-Tse TsanPau-Chung Chen
Jul 18, 2012·Nature Reviews. Rheumatology·Daniel J WallaceSwamy R Venuturupalli
Sep 26, 2013·Current Opinion in Rheumatology·Payam Mohassel, Andrew L Mammen
Oct 26, 2013·Clinical and Experimental Nephrology·Ashish Upadhyay
Feb 1, 2014·Autoimmunity Reviews·Andrea DoriaLeonardo Punzi
Mar 25, 2014·Annals of the Rheumatic Diseases·Patricia Ruiz-LimonChary Lopez-Pedrera
Aug 19, 2014·Lancet·Børge G Nordestgaard, Anette Varbo

❮ Previous
Next ❯

Citations

Jan 12, 2016·Bioorganic & Medicinal Chemistry Letters·Panagiotis Theodosis-NobelosEleni A Rekka
May 27, 2016·Current Opinion in Rheumatology·Laura B Lewandowski, Mariana J Kaplan
May 5, 2017·Expert Review of Clinical Immunology·Luis Alonso González, Graciela S Alarcón
Oct 19, 2017·Current Atherosclerosis Reports·Michael Garshick, James A Underberg
Jun 6, 2018·Current Opinion in Rheumatology·Yudong Liu, Mariana J Kaplan
Sep 3, 2018·The Journal of Rheumatology·April M JorgeHyon K Choi
Jul 28, 2019·Arthritis & Rheumatology·Sang Yeop KimAnna Schwendeman
Jun 9, 2020·Expert Opinion on Pharmacotherapy·Paramarjan Piranavan, Andras Perl
Jun 12, 2020·Arthritis & Rheumatology·Sen Hee TayAnna-Marie Fairhurst
Nov 22, 2016·Lipid Insights·Jonathan T DaviesHollie I Swanson
Nov 1, 2018·Rheumatology·Giuseppe A RamirezHannah Cohen
Dec 28, 2019·Current Vascular Pharmacology·Myrto KostopoulouGeorge Bertsias
Jan 2, 2021·Seminars in Arthritis and Rheumatism·Devin AbrahamiSamy Suissa
May 4, 2020·International Immunopharmacology·Abbas ShahiAliakbar Amirzargar
Oct 2, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yingjian DengXin Su
Apr 20, 2021·Frontiers in Immunology·Jingtao QiuCornelia M Weyand
Apr 27, 2021·Frontiers in Pharmacology·Weilin ChenHonglin Zhu
Jun 8, 2021·Journal of Lipid and Atherosclerosis·Daehong KimYeonseok Chung
Jul 25, 2021·International Journal of Molecular Sciences·James Greenan-BarrettCoziana Ciurtin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.